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Human α-lactalbumin made lethal to tumor cells (HAMLET) is a tumoricidal complex consisting of human
α-lactalbumin and multiple oleic acids (OAs). OA has been shown to play a key role in the activity of HAMLET
and its related complexes, generally known as protein–fatty acid (PFA) complexes. In contrast to what is
known about the fate of the protein component of such complexes, information about what happens to OA
during their action is still lacking. We monitored the membrane, OA and protein components of bovine
α-lactalbumin complexed with OA (BLAOA; a HAMLET-like substance) and how they associate with each
other. Using ultracentrifugation, we found that the OA and lipid components follow each other closely. We then
firmly identify a transfer of OA from BLAOA to both artificial and erythrocyte membranes, indicating that natural
cells respond similarly to BLAOA treatment as artificial membranes. Uncomplexed OA is unable to similarly
affect membranes at the conditions tested, even at elevated concentrations. Thus, BLAOA can spontaneously
transfer OA to a lipid membrane. After the interaction with the membrane, the protein is likely to have lost most
or all of its OA. We suggest a mechanism for passive import of mainly uncomplexed protein into cells, using
existing models for OA's effect on membranes. Our results are consistent with a membrane destabilization
mediated predominantly by OA insertion being a significant contribution to PFA cytotoxicity.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
The phenomenon of cytotoxic protein–oleic acid
(OA) complexes has received continuous attention
in recent years, in particular, human α-lactalbumin
made lethal to tumor cells (HAMLET) and its related
complexes [1–5]. Such complexes are more gener-
ally known as protein–fatty acid (PFA) complexes
and the focus these have received are partly due to
their possible clinical potential—HAMLET has been
through several trials of medical relevance [6–8].
The precise nature of the complexes and exact toxic
mechanism has been subject to scrutiny. The
protein–OA complexes are prepared from bovine
α-lactalbumin (BLA; BAMLET) [1], equine lysozyme
[equine lysozyme complexed with OA (ELOA)] [2],
goat α-lactalbumin [9] and other proteins that are
made to bind OA using a variety of approaches,
including passage of the protein through a column
equilibrated with OA [2,4], direct titration of OA into aAuthors. Published by Elsevier Ltd. This
rg/licenses/by-nc-nd/4.0/).protein solution [3,10] and heat treatment [9,11].
HAMLET was initially thought to consist of one OA or
only a few OAs initially described as “cofactors” [12].
It has later become clear that the complex consists of
many OAs per protein molecule (ratios of up to 1:48
has been reported) [2,3,10] and that the main
cytotoxic component is the fatty acid [13]. When
bound to the protein, the fatty acid appears to be
predominately in its deprotonated oleate form and
the binding has a significant electrostatic component
[14,15]. It is uncertain whether the protein part of the
complex has a role beyond being a solubilizer and
carrier of OA, which is insoluble but have toxic
properties. HAMLET and ELOA complexes do form
annular oligomers in the presence of lipid mono-
layers more effectively than the native protein
that also forms these under the same conditions to
some extent [2,16]. These pore-like formations are
associated with cell death and the destruction of
cellular membranes, at least in systems related tois an open access article under the CC BY-NC-ND license
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3178 Protein complex transfers oleic acid to membranesneurodegeneration [17,18]. Ion fluxes and large
effects on the cellular membranes have been
observed for HAMLET-treated cells [19], and one
of the key characteristics of the complex appears to
be its high affinity for the lipid membrane and the
destabilizing effect it has upon it [20].
Recently, we published a paper focusing on the
effects that one such PFA complex has on the lipid
membrane [21]. We prepared bovine α-lactalbumin
complexed with OA (BLAOA), a complex similar to
BAMLET, using a simple incubation of BLA in the
presence of OA under mild conditions favoring
partial unfolding (Ca2+ depletion and 37 °C) [22].
This approach provides the opportunity to form
BLAOA with varying amounts of OA included in the
complex. Our subsequent analysis showed that
both the complex ability to induce leakage and
cell death correlated well with the amount of OA
bound in the complex. We also noted large changes
in the packing environment of lipid molecules in
large unilamellar vesicles (LUVs) treated with
BLAOA relative to controls. Earlier studies per-
formed by Nielsen et al. on ELOA suggested that
OA is transferred to the target membrane [23].
Although there have been numerous studies that
label and track the protein component of HAMLET
and similar complexes at membranes and in cells
[2,23,24], there is a lack of information about what
happens to the OA component. Very recently, the
transfer hypothesis formulated by Nielsen et al. for
the ELOA complex has been forwarded again in the
context of studying erythrocytes treated with BAM-
LET, which causes eryptosis by a detergent-like
action [25]. The authors find it likely in their
discussion that OA (or oleate) is transferred to
the erythrocyte membrane as part of the eryptosis
mechanism, but they did not proceed to investigate
this possibility further. In the current work, we relieve
the lack of information on the fate of OA by
identifying a transfer of OA from the complex to
artificial membranes. The chemical shift of the
carboxylate carbon of OA is a useful tracker of how
saturated the BLAOA complexes are with respect to
the fatty acid component. We use this shift depen-
dency to track the effect that membrane has on
the BLAOA complex, and we conclude that the
changes observed can only be explained by a
transfer to the membrane. Finally, we show that a
similar transfer also occurs when erythrocytes are
treated with BLAOA, and we isolate the purified
erythrocyte membrane fraction and show that it
contains OA that cannot be ascribed to any
remaining BLAOA. Transfer and embedment of OA
into the cellular membrane would lead to its
destabilization and, for large doses, their complete
disruption. Using existing frameworks for under-
standing OA effect on membranes [26], we propose
an explanation for how the protein component of
PFA complexes can be detected in the cytosol andmany other places in the cell without invoking active
transport as an explanation. Our results also have
implications for how the many proposed cellular
targets of HAMLET is interpreted, as the protein is
likely to enter the cell without much OA attached.Results
Chemical shifts of OA as a function of BLAOA
complex saturation
To characterize the BLAOA complex used in this
study and how increasing the amount of OA relative
to BLA affects the chemical environment of the
carboxylate of the fatty acid, we performed NMR
spectroscopy. BLAOA was prepared by OA labeled
with 13C at the carboxyl carbon (1-13C OA), and
NMR spectra of BLAOA were obtained as a function
of BLA:OA molar ratios (Fig. 1A). All the spectra
show only one peak from the OA carboxyl carbon,
although there may be small amounts of excess OA
present after the preparation of BLAOA. For com-
parison, reported parts per million (ppm) values for
bound oleate and OA HAMLET prepared using a
column pre-incubated OA are indicated (Fig. 1A)
[27]. The peak in the carboxyl region of the 13C NMR
spectrum of BLAOA is from bound OA, since
fatty acids in aqueous solution self-assemble into
high-order structures and have extremely broad
carboxyl resonances that cannot be observed
(Fig. 1A, inset, and Ref. [28]). The peak positions
are plotted against OA-to-BLA molar ratios in Fig. 1B.
The peak moves upfield when increasing the amount
of OA used to prepare the complex. For example, the
peak for BLAOA1:80 is at 179.1 ppm, 1.2 ppmupfield
from its position at 180.3 ppm for BLAOA 1:2. This
overall trend toward lower ppmvalues is, however, not
unbroken. There is a local ppm maximum at BLAOA
1:20. Also, for BLAOA 1:5, 1:10 and 1:20, the peak
positionwasprone to fluctuation in parallels. For larger
ratios, the standard deviation was much lower.
OA is associated with the membrane after
BLAOA–membrane interaction
We have shown earlier that BLAOA and HAMLET
interact strongly with lipid membranes and perturb
the membrane with respect to both its lateral packing
and its integrity [20,21]. To investigate to what extent
the fatty acid component, the protein component
or the complex as a whole associates with the
membrane, we performed ultracentrifugation on egg
yolk phosphatidylcholine (EYPC):porcine brain
phosphatidylserine (PBPS) LUVs treated with BLA,
OA and BLAOA, using a self-generating iodixanol
gradient [29]. Such self-generated gradients provide
a straightforward way of fractionating membrane
Fig. 1. Characterization of BLAOA complex by
NMR spectroscopy. (A) Representative 13C NMR
spectra of BLAOA (prepared using 1-13C OA)
obtained as a function of BLA:OA molar ratios.
BLA:OA 1:2 ( ), BLA:OA 1:20 ( ), BLA:OA 1:40
( ) and BLA:OA 1:80 ( ). All spectra show the
peak of the 13C-labeled OA carboxyl carbon and are
scaled to take into account the number of scans and
total OA present in sample. No other carbon signals
were detected in the spectral range. Protein concen-
tration was held constant at 200 μM. (B) Chemical
shift of the OA carboxyl carbon changes with
BLA:OA molar ratios (ANOVA, P ˂ 0.01). Inset:
Representative controls with same amount of
uncomplexed OA as used to prepare the complexes.
Control for BLA:OA 1:2, 56 μg (400 μM) OA present
( ); control for BLA:OA 1:40, 1128 μg (8 mM) OA
present ( ); control for BLA:OA 1:80, 2256 μg
(16 mM) OA present ( ). In both main panel and
inset panel, ↓* and ↓** indicate the ppm values
reported by Ho et al. for oleate and OA in HAMLET,
respectively [26].
3179Protein complex transfers oleic acid to membranesvesicles and macromolecular complexes. Compo-
nents that have different densities but are strongly
associated with each other will end up in the same
fraction. The distribution profiles of lipids (in the form
of LUVs and detected by the fluorescent dye Dil
embedded in the membrane) for different samples
are shown in Fig. 2A. One can see that only BLAOA
caused the membrane distribution in different
fractions to change. Compared with the distribution
profile for LUVs only, BLAOA-treated LUVs ended
up more in the denser fractions (fractions 1 and 2)
while less in those of lower density (fraction 9).
This indicates that BLAOA treatment caused the
lipid membranes to become denser. Similar to the
membrane distribution profile in Fig. 2A, after the
ultracentrifugation, most of the OA also ends up in
the lighter fractions (solubilized in methanol and
detected by 13C NMR spectroscopy), as shown in
Supplementary Information Fig. S1a. For LUVs
treated with OA alone, OA was not detected by
NMR in any of the fractions (but later detected on the
test tube walls after centrifugation; see Fig. S3).
Unlike the membranes and OA, the protein com-
ponent (detected by NanoOrange), after the ultra-
centrifugation, is evenly distributed in every fractionfor both BLAOA- and BLA-treated LUVs (Supple-
mentary Information Fig. S1b), except for a slight
rise in amount in the fraction of lowest density
(fraction 10), which is not seen for BLAOA or BLA
centrifuged alone. In Fig. 2B, the distribution profiles
of the membrane, protein and OA for BLAOA-treated
LUVs are plotted together for easier comparison. As
can be seen, OA and the lipid membranes have very
similar distribution profile; that is, OA follows the
membranes in all the fractions. The protein compo-
nent is not strongly associated with the membranes
on the timescale of the experiment (3 h), and OA and
protein are not associated with each other. The
association of the OA component of BLAOA with the
membrane was also confirmed using size-exclusion
chromatography (Supplementary Information Fig.
S2).
Changes of BLAOA complex in response to LUV
treatment
It was earlier established by several laboratories
that PFA complexes have a high affinity to mem-
brane, but these studies did not examine the fate of
the fatty acid component separately [20,21,23]. Very
Fig. 2. Fractionation of LUVs treated with BLAOA, BLA
and OA and LUVs untreated in a self-generated 10%
iodixanol gradient. A typical density profile of fractions 1–
10 is indicated by (– – –) and ranges from 0.945 g/mL to
0.970 g/mL. (A) Membrane distribution profiles, where the
lipid content of each fraction is assayed by measuring the
fluorescent intensity of a fluorescent dye Dil embedded in
the membrane. Samples are subject to BLAOA ( ), BLA
( ) and OA ( ) and left untreated ( ).
(B) Comparison of the distribution of membrane ( ),
protein ( ) and OA ( ) after fractionation of BLAOA-
treated LUVs. Protein content of each fraction is assayed
using NanoOrange Protein Quantitation Kit. OA content
of each fraction is assayed by measuring the intensity of
the peak for OA carboxyl carbon in 13C NMR spectra of
different fractions. To be able to detect the total signal, we
solved the fractions in methanol.
3180 Protein complex transfers oleic acid to membranesrecently, erythrocytes were reported to undergo
eryptosis-like behavior upon BAMLET treatment,
and the authors of this paper again discuss transfer
of OA from complex to the membrane [25]. The
results presented above indicate that the fatty acid
component of the complex follows the membrane
closely. We are interested in knowing whether this
is the result of a wholesale transfer or just an
association between the BLAOA complex and the
membrane. Since the chemical shift of OA carboxylcarbon is sensitive to the BLA:OA molar ratio in
BLAOA, it can be used as a tracker to access the
complexation state of BLA to OA in the complex
during membrane interactions. We monitored
the change in the 13C NMR chemical shift of OA
carboxyl carbon in BLAOA (BLA:OA 1:40, 160 μM)
during titration by EYPC:PBPS LUVs and the results
are shown in Fig. 3. One can see that, upon adding
LUVs, the peak moves upfield from 179.67 ppm
for the complex alone to 179.16 ppm as the lipid
concentration reaches 600 μM. In addition, there are
clear changes in the signal linewidth and intensity
during the titration, further indicating a change in the
environment of the OA. The chemical shift change
and line broadening is consistent with a transfer of
the OA to a more hydrophobic and slow-tumbling
environment.
Interaction of BLAOA with erythrocytes
The titration of BLAOA with LUVs showed signif-
icant changes in the chemical environment of the
carboxylate carbon of the OA factor that were not
compatible with a simple stripping of the complex,
which would have led to the peak moving downfield.
Membrane effects have been linked to the efficacy
of HAMLET-like complex on target cells [20,23].
We are interested whether natural cell membranes
elicit similar responses, and we choose erythrocyte
membranes. Erythrocytes are easily isolated and,
unlike most other cell types, they have a simplified
outer membrane structure and they lack nucleus and
other organelles. We proceed to titrate BLAOA 1:40
with erythrocytes instead of LUVs and record the 13C
NMR spectrum of BLAOA during the interactions
(Fig. 4A). Instead of a continuous movement upfield
as was observed in response to LUVs treatment,
the addition of erythrocytes to BLAOA results in a
slight downfield movement of the OA carboxyl
carbon peak from 179.27 ppm before movement
upfield to 179.52 ppm at the titration endpoint
(Fig. 4B). Moreover, the signal intensity decreases
upon erythrocyte titration.
The drop in signal intensity was not seen as clearly
for the LUV titration. There is also a question in both
the LUV and erythrocyte instance about the fate of
the OA. Clearly, the OA signal is perturbed in a
manner consistent with an association with the
membrane, but whether the disappearance of the
signal is due to a transfer and embedment into the
membrane is unclear. It is to be expected that the OA
signal is difficult to detect when the molecule is
completely embedded in a large aggregate such as
a LUV and even more so in the case of the very large
(50-fold larger) erythrocyte. To investigate whether
we could find evidence for a complete transfer to
erythrocyte membranes, we performed 13C NMR on
isolated cell membranes from erythrocytes treated
with BLAOA 1:40 (Fig. 5A). Indeed, we observe a
Fig. 3. OA experiences microenvironmental
changes during titration of BLAOA (BLA:OA 1:40)
with LUVs. (A) 13C NMR spectra recorded upon
titration of BLAOA (prepared using 1-13C OA) with
LUVs. No LUVs present ( ); 100 μM LUVs
present ( ), 200 μM LUVs present ( ) and
600 μM LUVs present ( ). Protein concentration
in each sample is 160 μM. (B) The chemical shift of
the OA carboxyl carbon in response to increasing
amounts of LUVs. Inset: Representative controls
for the titration performed with the same amount of
uncomplexed OA as used to prepare BLA:OA 1:40,
corresponding to a total of 906 μg OA per sample;
100 μM LUVs present ( ), 200 μM LUVs pres-
ent ( ) and 600 μM LUVs present ( ). In both
main panel and inset panel, ↓* and ↓** indicate the
ppm values reported by Ho et al. for oleate and OA
in HAMLET, respectively [26].
3181Protein complex transfers oleic acid to membranesclear signal from OA, which is rather low when the
sample is scanned without further effort to resolve
it but which is significantly boosted when methanol
and SDS are added, dissolving OA completely and
dissolving lipid and OA molecules into a solution
of mostly monomers. We also show that the sample
is practically free of BLA, which is only detected
by anti-BLA in the supernatant after BLAOA treat-
ment (Fig. 5b). The control experiments subjecting
erythrocytes to similar amounts of uncomplexed OA
show no detectable OA in any fraction (Fig. 5A and
B, inset), confirming that BLA complexation of
OA is necessary for this behavior. Further control
experiments relocate the OA in the test tube after
spinning down the erythrocyte control sample after
the 4-h exposure to OA or BLAOA, as described in
Materials and Methods (Supplementary Information
Fig. S3).Discussion
Tracking the chemical environment of OA in
complex with BLA and lipid membranes required
us to first investigate the relationship betweenBLA:OA molar ratios used to prepare the complex
and the OA carboxylate chemical shift. As expected,
the OA carboxyl carbon chemical shift is dependent
on the BLA:OA ratio in BLAOA (Fig. 1), indicating
that the magnetic microenvironment of OA changes
with OA content in the complex. In general, the
chemical shift of OA carboxyl carbon moves upfield
upon addition of OA to BLA, indicating a slightly
more shielded environment for the carboxyl group
of OA as the complex becomes more saturated
with OA. The 13C NMR methodology used here
has been used in earlier works to identify different
types of binding sites of OA to bovine serum albumin
where multiple carboxyl peaks appeared [28].
There are also reports available for the more closely
related complex HAMLET. The HAMLET 13C NMR
spectrum shows clear peaks for oleate and OA at
about 180.9 ppm and 178.1 ppm, respectively [27].
Similarly, the work of Forato et al. shows that OA
storage proteins can bind OA using either a
predominantly electrostatic mode or a predominantly
hydrophobic mode [30]. In contrast, in this study,
only a single, broad carboxyl peak, whose position is
dependent on the BLA:OA ratios in the complex, was
observed. This is best explained by fast exchange
Fig. 4. OA experiences microenvironmental
changes during titration of BLAOA (BLA:OA 1:40)
with erythrocytes. (A) 13C NMR spectra recorded
upon titration of BLAOA (prepared using 1-13C OA)
with increasing number of erythrocytes; 0.7 billion
cells present ( ), 2.7 billion cells present ( ),
10.7 billion cells present ( ) and 42.8 billion cells
present ( ). Protein concentration in each sample
is 100 μM. (B) Chemical shift of the OA carboxyl
carbon changes during titration. The range of the
chemical shift axis is the same as in Fig. 3B. Inset:
Representative controls with same amount of uncom-
plexed OA as for the BLA:OA 1:40 in the main
experiment, that is, 566 μg per sample; 0.7 billion
cells present ( ), 10.0 billion cells present ( )
and 41.6 billion cells present ( ). In both main
panel and inset panel, ↓* and ↓** indicate the ppm
values reported by Ho et al. for oleate and OA in
HAMLET, respectively [26].
3182 Protein complex transfers oleic acid to membranestaking place between a range of closely related
chemical environments, where electrostatically dom-
inated oleate binding on one hand and hydrophobic
OA binding on the other hand define the extremes.
That a distribution rather than two distinct environ-
ments are observed underlines the fact that BLAOA
is not exactly the same as HAMLET or BAMLET.
BLAOA does retain HAMLET key properties, how-
ever, such as being highly cytotoxic and having large
effects on membranes [20,21]. For column-prepared
HAMLET [12], bound fatty acid is predominantly in its
oleate form, that is, analogous to the electrostatic
mode reported by Forato et al. for bovine serum
albumin [30]. For BLAOA prepared at low OA:protein
ratios, the 13C chemical shift of bound OA is closest
(180.3 ppm for BLAOA 1:2; Fig. 1B) to the values
reported by Ho et al. for oleate binding. However, the
average environment becomes more similar to that
of OA binding as ratios increase (179.1 ppm for
BLAOA 1:80; Fig. 1B).
Our earlier results indicate that BLAOA may
incorporate into the lipids upon membrane interac-
tion and cause a tighter lipid packing in the
membrane [21]. The membranes become denser
after being treated with BLAOA (Fig. 2A), indicating
that the complex and/or its components haveinteracted with and altered the properties of the
membranes. BLA or OA alone did not cause obvious
changes to the LUV distribution profiles, suggesting
little effect on the membranes under these condi-
tions. Furthermore, from Fig. 2B, one can see that it
is the OA component of BLAOA that is associated
with the membranes after the complex–membrane
interaction. The protein component, on the other
hand, is strongly associated neither with the mem-
branes nor with OA. This suggests that the complex
transfers fatty acid from protein component to lipid
membranes upon membranes interactions. This is
consistent with previous findings for BLAOA and
ELOA reporting at least partially protein disasso-
ciated from the fatty acid [21,23]. Although the
protein component is rather evenly distributed in all
the fractions after the ultracentrifugation, indicating
that the protein is well dissolved in the sample
solution and therefore could not be fractionized,
there is a small but notable increase of protein
component in the lightest fraction where most of the
LUVs also reside, showing that the protein does
associate weakly with the lipid membranes. This is
also observed for BLA-treated LUVs (Fig. S1b),
suggesting that this weak interaction of protein with
lipid membranes is a general property of the protein
Fig. 5. Transfer of OA to erythrocyte membranes upon
treatment with BLAOA (BLA:OA 1:40). (A) 13C NMR on
isolated cell membranes from erythrocytes treated with
BLAOA before ( ) and after ( ) being reconstituted in
methanol and SDS. Inset: Control experiments showing
13C NMR on isolated cell membranes from erythrocytes
treated with OA only (i.e., equivalent amounts as present in
the BLA:OA 1:40 experiment) before ( ) and after ( )
being reconstituted in methanol and SDS. In both main
panel and inset panel, ↓* and ↓** indicate the ppm values
reported by Ho et al. for oleate and OA in HAMLET,
respectively [26]. (B) The location of BLA and OA tracked
throughout membrane isolation process by dot blot probed
with anti-BLA and 13C NMR, respectively. For the control
(topmost row, indicated by first green bracket) where
erythrocytes were treated only with equivalent amounts of
OA prior membrane isolation, only 13C NMR was
performed. The Input column shows 10 ng of BLAOA
from the stock solution used in the experiment and all
samples are loaded equally. The BLAOA column refers
to the supernatant after BLAOA treatment of erythrocytes.
Lysate shows the supernatant after the initial treatment
with 5 mM ice-cold Tris–HCl (pH 7). Wash I and Wash II
display the two subsequent washing steps. EDTA shows
the supernatant after treatment with 1 mM EDTA.
Membrane displays the isolated membrane fraction. To
obtain a stronger OA signal, we reconstituted the membrane
fraction in methanol and SDS in the final row.
3183Protein complex transfers oleic acid to membranesand can happen with or without the help of OA.
Indeed, the calcium-depleted, apo-BLA has been
reported to bind weakly to lipid membranes at neutral
pH values [31,32]. This is inline with our findings and
is inline with the protein component's tendency tointeract weakly with many substances [22]. In the
control experiments where BLA or BLAOA was
centrifuged alone without any LUVs being added,
the protein distribution was the same in every
fraction.
The disassociation of BLA from OA caused by
membrane interactions was tracked by following the
chemical shift of OA carboxyl carbon (Fig. 3), which
is dependent on the BLA:OA ratio in BLAOA (Fig. 1).
During the titration of BLAOA with LUVs, if more and
more OA is stripped away from the complex to the
membranes, one would expect that the chemical
shift of OA carboxyl carbon would move downfield
(Fig. 1). However, we observed the opposite trend
(Fig. 3); that is, the peak moved upfield upon adding
LUVs. We interpret this as OA being inserted wholly
or partially into the lipid membranes while remaining
detectable by NMR. The slow tumbling and dipolar–
dipolar relaxation in the membrane is expected to
broaden the OA resonance, but it seems that we
were still able to observe a membrane environment
for OAs associated with LUVs of 110 nm hydrody-
namic diameter (as determined by dynamic light
scattering). The broad nature of the signals involved
means that one cannot distinguish OA bound to the
membrane from OA bound to BLA. The peak
observed has contributions from mainly protein-as-
sociated and the mainly lipid-associated OA that in
sum cause the average signal to move upfield
as more vesicles are added. As can be seen from
Fig. 1A, the peak of OA in BLAOA is relatively sharp.
However, the addition of LUVs makes the OA
resonance weaker and broader (Fig. 3), consistent
with a transfer of OA from BLA to membranes. While
LUVs have a hydrodynamic diameter of about
110 nm, erythrocytes are much larger (1000–
5000 nm in diameter), and thus, NMR signals from
factors that are embedded in their membrane are
expected to be unobservable. Therefore, a stripping
of OA from the complex during erythrocytes treat-
ment will cause the chemical shift of OA carboxyl
carbon to move downfield and the signal to become
weaker as we were left only with the signal from the
remainder of the complex. This is exactly what is
observed (Figs. 1A and 4A). Moreover, we isolate
the BLAOA-treated (1:40) erythrocyte membranes,
washed away excess complex and showed that
labeled 13C carboxylate could be identified in the
membranes (Fig. 5). This behavior is only observed
when erythrocytes are treated with BLAOA. Control
experiments using equal amounts of OA (8 mM) is
not transferred to the membrane in this manner. All
experiments performed points toward BLAOA effec-
tively being able to transfer OA to both LUV and
membranes, while OA in the absence of the protein
is not able to do so. This is indicative of a situation
where the main role of the protein is to keep the OA
soluble and available for effective interaction with the
membrane, inline with what other authors have
3184 Protein complex transfers oleic acid to membranessuggested earlier [9,13,24], and recently also for
PFA action on erythrocyte cells [25].
In the case of experiments tracking the OA
chemical shift, the resulting trends recorded can be
explained in terms of observable (in the case of
LUVs) and non-observable (in the case of the much
larger erythrocytes) NMR signals. We conclude
that BLAOA can effectively transfer OA to lipid
membranes using a mechanism that is independent
of active transport. That is not to say that cells other
than the simple erythrocytes may not respond
actively to PFA treatment, merely that it is not
necessary to postulate involvement of cellular
machinery to achieve transfer as a first step of
PFA's action. The LUV experiments where we see
an average signal of both protein-associated and
lipid-associated signals open for the question about
what the lipid-associated situation is like. Are the OA
molecules completely embedded in the membrane,
and is the membrane packing much perturbed by
this? The final experiment where we relocate the OA
signal in the membrane fraction of erythrocytes only
after we treat the sample with methanol and SDS
indicates that the OA is embedded in the membrane.
Insertion of OA into a bilayer would be disruptive to
its packing. One important determinant of membrane
shapes is the difference in tensions between
the inner and outer membrane leaflets [26,33]. This
difference is caused by the molecular area in each
leaflet and the geometry of the components and
the forces acting between them. If OA or oleate is
inserted in the outer leaflet, this would strain the
configuration of the bilayer until a new equilibrium is
reached by transfer of molecules between leaflets
[34]. In addition to spontaneous and relatively slow
flip-flop behavior of membrane components, it has
been proposed that transient membrane defects
contribute to the transfer to the inner leaflet in a
tension-dependent manner [35,36]. That is, the more
tension there is between inner and outer leaflets due
to BLAOA action, the stronger this effect would
be. BLAOA adversely affects the integrity of the
membrane in a manner that is proportional to the
amount of OA in the complex, and a concomitant
tightening packing of the leaflet structure is observed
[21]. Thus, BLAOA seems to provide both the
necessary tension and the necessary defects for
this mechanism to be effective. The proponents
of this mechanism also suggest that other molecular
species can be transferred in this way. The
spontaneous import of HAMLET observed in many
studies [20,37] may actually be due to such a
tension-driven influx. Intercalation of oleate in
particular would favor the formation of structures
with positive curvature. Simple exposure to slurries
of OA at slightly (pH 8.8) basic conditions can greatly
affect the membrane structure of giant unilamellar
vesicles [26]. Among effects seen are rapid invag-
ination and eventual collapse of vesicles [26], in amanner very similar to those reported by us when
exposing giant unilamellar vesicles to BLAOA at
physiological conditions [21].
This observation may explain why cells treated
with HAMLET experience broadly increased ion
fluxes that are only partially inhibited by known
blockers of ion channels [19]. Our results also
indicate that the OA component of the BLAOA and
similar complexes tend to end up in the membrane,
rather than remaining in the complex. There are
many reports, mostly based on tracing of the protein
component of HAMLET, that it enters the cell and
associates with a wide range of organelles and
individual protein components [37–39]. Our current
finding indicates that much, if not all, of the OA gets
stripped away by contact with the membrane forcing
the question as to whether internalized HAMLET is
still HAMLET. At the very least, studies tracing
HAMLET by its protein component alone should be
interpreted with caution, as the most active part of
the complex, that is, OA, may have been stripped
away to a large extent. At least some of the effects
and interactions reported for HAMLET and similar
complexes could conceivably be caused by the
protein component alone, since the apo-form of
human α-lactalbumin that remains after full or partial
shedding of OAs will be partially unfolded and thus
prone to interact to some extent with multiple targets
[22]. It is also not always clear whether any given
interaction implied in HAMLET action is actually
causing cell death or whether the cell is already
dying from another primary cause. It is clear,
however, that complex binding to the lipid membrane
has significant disruptive effects [16,20,21,23]. For
some experimental setups, for instance, those
employing complexes saturated with OA such as
here, this may be sufficient to kill the cell outright.Materials and Methods
Materials
BLA [type III, calcium-depleted, ≥85% (PAGE)], deute-
rium oxide (99.9%), Wilmad NMR sample tubes (5 mm,
500 or 600 MHz, L7) and OptiPrep Density Gradient
Medium [60% (w/v) solution of iodixanol in water] were all
purchased from Sigma. We obtained 99% EYPC and
PBPS lipids from Avanti Polar Lipids, Inc. We obtained
1-13C OA (1-13C OA, oleic acid labelled with 13C in
position 1) from Cambridge Isotope Laboratories, Inc. We
acquired NanoOrange Protein Quantitation Kit and Dil
Stain fromMolecular Probes (Invitrogen). Anti-α-lactalbumin
antibody specific for bovine was acquired from Abcam.
Blood with K3EDTA (EDTA, ethylenediaminetetraacetic
acid) as an anti-coagulant was donated to us by Haukeland
University Hospital Department for Immunology and Trans-
fusion Medicine, Bergen, Norway, and used for isolating
erythrocytes. All other chemicals were from Merck.
3185Protein complex transfers oleic acid to membranesErythrocyte isolation
Erythrocytes were isolated from blood provided by
Haukeland University Hospital. Briefly, the blood was
stored for 72 h at 4 °C to allow reticulocytes to mature.
Then, the blood was centrifuged (650g, 5 min), and
plasma, buffy coat and 30% of the erythrocytes were
removed by aspiration. The remaining cells were washed
four times. The washing buffer consisted of 10 mM Tris–
HCl (pH 7), 0.9% NaCl and 5 mM glucose. The cells were
either used directly for titrations against BLAOA monitored
by 13C NMR or treated with BLAOA prior to isolation of
their membranes.Isolation of erythrocyte membranes
Erythrocytes treated with BLAOA or untreated cells were
centrifuged (650g, 5 min), and subsequently, supernatant
was removed by aspiration. Then, the cells were resus-
pended in ice-cold 5 mM Tris–HCl (pH 7) to allow
complete lysis and centrifuged (9000g, 20 min). This
process was repeated until the hemolysate appeared to
be colorless; most times, two washes were enough. The
isolated ghost membranes were treated with 0.1 mM
EDTA and 5 mM Tris–HCl (pH 7) for 30 min at 37 °C,
then the ghost membranes were centrifuged (20,000g,
30 min). Then the supernatant was removed by aspiration
and the isolated membranes were resuspended in 5 mM
Tris–HCl (pH 7) or 5 mM Tris–HCl (pH 7), 50%MeOH and
1% SDS and the presence of OA was identified by 13C
NMR. Supernatants collected throughout the procedure
were analyzed by dot blotting with anti-BLA to track the
location of BLA.Preparation of the BLAOA complexes
BLA was added to phosphate-buffered saline (10 mM,
pH 7.5) to make stock solutions at 400 μM. All the protein
concentrations are given in terms of monomeric protein
concentration in this work. OA was then added as pure
liquid, directly into the solution of BLA to reach a desired
BLA:OA molar preparation ratio. BLA:OA molar ratios
ranging from 1:2 to 1:80 were prepared for this study. For
instance, the amount of pureOA liquid needed for 2 mLBLA
stock solution (400 μM) was 10 μL in the case of BLAOA
1:40. The BLA andOAmixture was subsequently incubated
on a shaker for 1 h at 37 °C. For NMR experiments, 5%
deuterium oxide was added to achieve lock.Preparation of the phospholipid vesicles
LUVs were prepared from EYPC and PBPS. The
prerequisite amount of chloroform-dissolved 1:1 molar
ratio mixture of EYPC:PBPS was added to a glass tube
wrapped in aluminum foil. The chloroform solution was
dried to a thin lipid film using a nitrogen stream and
residual chloroform was removed under vacuum for 4 h.
The sample was then mixed with phosphate-buffered
saline (10 mM, pH 7.5) and left to hydrate overnight on a
shaker at 37 °C. To prepare LUVs, we subjected the
solution to seven freeze/thaw cycles using liquid nitrogenand a warm water bath. The sample was then extruded
through a 100-nm pore-size membrane (Nuclepore,
Whatman) 11 times using Avanti Mini-Extruder (Avanti
Polar Lipids, Inc.) and transferred to a clean tube.NMR spectroscopy
NMR experiments were performed on either a Bruker
AV600 instrument equipped with a QCI CryoProbe or a
Bruker AV500 equipped with a BBO probe. For a typical
pulse-and-acquire 13C experiment, 96 scans were accu-
mulated with a recycling delay of 1 s. The receiver gain
was set to 14,200, and a short delay “de” of 100 μs was
inserted between the end of pulse sequence and FID
accumulation to avoid baseline distortions. Processing in
Topsin in all instances used exponential multiplication as a
window function with a line broadening of 30 Hz. All
spectra were baseline adjusted using the manual interface
provided for this by Topspin. In some cases, the number of
scans and receiver gain setting was not the same for all
experiments. In these cases, the data were scaled to
match the other data presented. For identification of 1-13C
OA when the signal was completely obscured by line-
broadening effects, methanol was added to the samples to
completely dissolve all the OA molecules (final concen-
tration of up to 67% v/v methanol/water). In this way, the
resonance peak height could be used to compare the OA
content in different samples. This was performed for
experiments employing ultracentrifugation, the PD10
column and for the final detection of OA embedded in
the isolated erythrocyte membranes. This is noted in the
pertinent figure texts.Ultracentrifugation
The self-generating gradient (10%) was made by
diluting Optiprep Density Gradient Medium with DI water.
All the samples were centrifuged in 5-mL centrifuge tubes
in a Beckman Coulter SW 55 Ti swinging bucket rotor in
a Beckman Coulter ultracentrifuge (Optima LE-80K) at
50,000 rpm for 3 h, 24 °C. The rotor was allowed to
decelerate naturally with the brake off. The fractions
(300 μL each) were collected from dense end first. The
density profile was calculated from blank gradients with
known concentrations using a refractometer (Hanna
Instruments, Inc.).Fluorescence assays
Fluorescence assays for protein and lipid quantifications
were performed on Typhoon FLA 9000 laser scanner
(GE Healthcare Life Sciences). Protein quantification
assay was conducted using NanoOrange Quantitation
Kit (Invitrogen) according to the product's protocol. Briefly,
10 μL of each sample was diluted in the working solution to
achieve a final volume of 250 μL. The mixture was
then incubated at 95 °C for 10 min. All the samples were
cooled down to room temperature before being transferred
to a 96-well microplate. The fluorescence was measured
with excitation at 485 nm and emission at 590 nm. The
protein content in different samples was assayed by
comparing their fluorescence intensity (reagent blank
3186 Protein complex transfers oleic acid to membraneswas subtracted). For lipid quantification assay, a lipophilic
membrane stain Dil (1%) was added to the chloroform-
dissolved EYPC:PBPS mixture for preparation of LUVs.
The lipid content in different samples was then compared
by measuring the Dil fluorescence (excitation at 549 nm
and emission at 565 nm) in each sample.
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